Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand ... five-pack of injectable pens, says Lilly, which ...

But when adjusted for inflation, Eli Lilly’s list price for Humalog increased ... said they ration their insulin supplies to save money. Shortages will affect non-pen injectable insulins through ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition ... which is available in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into ...

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...

Drug company Eli Lilly announced it ... reports The New York Times. Lilly will also be reducing the price of its most prescribed insulin brands Humalog and Humulin by 70 percent.

and fast-acting insulin Humalog. And that's before we get into the company's pipeline, which features plenty of investigational drugs beyond Eli Lilly's core area of diabetes and obesity.

Humalog + Insulin Lispro have maintained a dominant market share in the United States and are a key component of Eli Lilly's revenues. Sales growth of 67% in the United States and 5% on an ...

Eli Lilly and Company discovers ... The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin ...